Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-078675

Options or other derivatives

  • Director acquired 15,806 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ryan David P. Director 2024-06-26 Grant or award · Stock Option (Right to Buy) +15,806 15,806 D
Loading xslF345X05/ownership.xml…